Aims: This systematic review and meta-analysis (registration number: CRD42013005825) compares the effects of low carbohydrate diets (LCDs) on body weight, glycaemic control, lipid profile and blood pressure with the effects of higher carbohydrate diets (HCDs) in adults with type 2 diabetes.
| INTRODUCTION
Dietary advice is generally accepted as a cornerstone of the management of type 2 diabetes (T2DM). 1 More than 80% of all patients presenting with T2DM are overweight or obese, 2, 3 and recommendations relating to energy intake and physical activity aimed at weight management are a core component of treatment for T2DM worldwide. [4] [5] [6] [7] However, advice regarding the macronutrient composition has varied over time. 8 With occasional exceptions, carbohydrate restriction was a key component of diabetic dietary prescriptions for much of the 20th Century. In the 1960s it became evident that CHD rates were exceptionally high in individuals with diabetes and the high intake of fat, predominantly saturated fat, associated with the reduction in carbohydrate was presumed to be a contributory factor. This observation, together with demonstration of the beneficial effects of dietary fibre on glycaemic control and blood lipids in the 1970s, led to a change in the nutritional approach. Consumption of fibre-rich, lowglycaemic index carbohydrates was encouraged and total carbohydrate intake was liberalized in advice to individuals with diabetes, as well as populations at large. 4, [9] [10] [11] [12] [13] [14] More recent reports have suggested the potential of appreciable reductions in carbohydrate to facilitate weight reduction and improve glycaemic control, insulin sensitivity, blood pressure, HDL-cholesterol and triglyceride levels to a greater extent than higher carbohydrate diets. [15] [16] [17] [18] [19] However, three recent meta-analyses of trials undertaken in individuals with T2DM reached different conclusions regarding the merits of carbohydrate restriction in this patient group. 16, 20, 21 In order to provide information for an update of current European Guidelines for the management and prevention of diabetes, we have undertaken a systematic review and meta-analysis that attempts to circumvent the criticisms that have been directed at earlier attempts to aggregate the relevant trials. 22, 23 More specifically, we wanted to investigate whether a low-carbohydrate diet (LCD) improved weight and metabolic control more than a higher carbohydrate diet in patients with type 2 diabetes.
| MATERIALS AND METHODS
This systematic review was carried out according to Cochrane recommendations, 24 and was reported in line with the PRISMA Statement 25 (Table S1 ). The protocol for this review was prospectively registered in PROSPERO (CRD42013005825). MeSH terms when available. We also searched the reference list of identified studies and performed forward citation searches to consider studies not identified by our online search.
| Search strategy and study selection
We included randomized, controlled trials of parallel or cross-over design with a duration of more than 3 months in adults with type 2 diabetes. We had no restrictions regarding minimum number of included participants. Co-morbidity was accepted, but studies including individuals with impaired glucose tolerance and/or type 1 diabetes were included only whenever separate data for patients with type 2 diabetes were provided. To be included, trials must have compared a diet below to a diet above 40% total energy (E%) from carbohydrate.
Complex interventions with the potential to interfere with the effect of the dietary intervention, such as parenteral administration or promotion of physical activity, were excluded.
We included studies written in English, Danish, Norwegian and Swedish. One author screened all titles and abstracts and excluded obviously irrelevant records. For the remaining records, full-text articles were obtained and assessed independently for inclusion by two authors. Any disagreements were resolved by consensus.
| Data extraction and risk of bias
From each study we extracted the name of the first author, year of publication, study design, study duration, participant details, intervention diet details, markers of compliance with diets, and outcomes measured. The following outcomes were considered: weight, HbA1c, lipids, blood pressure and compliance with dietary intervention. Data were extracted by one author and verified by a second author.
We assessed risk of bias for the main items suggested by Cochrane
24
: random sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, incomplete outcome data, selective reporting and other sources of bias. For each study and outcome, two authors independently rated the seven domains as low, unclear or high risk of bias.
We applied the following criteria to assess overall risk of bias for each study and outcome.
• Low risk: No high risk of bias, and not more than two unclear risks of bias
• High risk: Two or more high risks of bias, one high and more than one unclear risk, or more than four unclear risks of bias
The remaining articles were classified as unclear risk of bias.
Because of the nature of delivery of dietary interventions, blinding of participants and study personnel who provided dietary advice was not possible. Hence, this item was not considered when assessing the overall risk of bias.
| Data synthesis and analysis
Results were summarized qualitatively and, whenever applicable, results from available studies were combined in meta-analysis using Review Manager (RevMan Version 5.3. Copenhagen, The Nordic
Cochrane Centre, The Cochrane Collaboration, 2014). We expected clinical heterogeneity among studies, and chose the random-effects model. The weighting of individual trials was defined by inverse variance and Mantel-Haenszel methods for continuous and dichotomous outcomes, respectively. We calculated the mean difference (MD) for continuous outcomes, whereas dichotomous effect sizes were expressed in terms of a risk ratio (RR). For trials with multiple dietary arms, we pooled data for the higher-carbohydrate diet groups to create one control group. 24 Crossover trials were not included in the meta-analysis because of the short intervention period and possible carryover effect. The HbA1c unit was converted from % to mmol/mol using a conversion calculator (http://www.ngsp.org/convert2.asp).
Meta-analyses were considered to be associated with heterogeneity when the I 2 value was above 50% and/or the P value of the Cochrane Q test was less than 0.10, 24 and subgroup analysis was used to explore possible reasons for the suggested heterogeneity. In partic- 15 and risk of bias (low vs high).
Two authors independently graded 26 the certainty of the evidence for diets of lower carbohydrate content when compared with diets of higher carbohydrate content in the management of type 2 diabetes. We assessed publication bias for a given outcome by inspection of funnel plots.
3 | RESULTS
| Search results and characteristics of the included studies
Out of 1589 studies identified through database searches and cross reference list matching, 23 studies were included in the review ( Figure 1 ). The main reasons for exclusion were diet intervention not being low-carbohydrate; duration of intervention being less than 3 months; study sample consisting of individuals without type 2 diabetes and studies using a non-randomized and/ or non-controlled trial design (Table S2 ). 32, 38, 42, 45, 47 five in Australia, 28, 29, 41, 44, 48 one in New Zealand, 43 three in Israel 34, 39, 40 and one in Japan. 49 A randomized crossover design was used in four studies, [27] [28] [29] 38 and 19 studies were parallel randomized control trials with one or two control groups. [30] [31] [32] [33] [34] [35] [36] [37] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] A summary of findings from the included studies is presented in 10 additional records identified through other sources FIGURE 1 PRISMA study eligibility flow chart HbA1c reduced (P < 0.001).
Greater reduction with the LCD (P = 0.02) TG reduced (P = 0.003).
Greater improvements in HDL and TG with the LCD (P = 0.03 and 0.003) SBP reduced (P = 0.048).
Greater reduction in DBP with the LCD (P = 0.03) No difference between groups
HbA1c increased (P < 0.0001).
No difference between groups LDL reduced (P = 0.0079).
No difference between groups DBP reduced (P = 0.0080).
Greater reduction in DBP with the LCD (P = 0.020) Not applicable g (Continues) Macronutrient value shows actual intake during study/end of study.
h P value on effect between groups not provided, but authors state that no difference was seen between the two diets; no information available on within-group effect.
i Data on macronutrient intake during study was extracted from the entire study population. 
| Risk of bias in included studies
Assessment of risk of bias is summarized in Figure S1A and is shown for the individual studies in Figure S1B . Method of random sequence generation was reported and found to be adequate in 15 studies.
Eight trials provided sufficient information concerning the proceedings of allocation concealment and they were rated as low risk. As expected, few studies blinded study participants and personnel to the dietary interventions, with the exception of one trial, 40 and were thus rated as unclear risk of bias. Five studies reported blinding of outcome assessors. 34, 41, 43, 46, 48 One study 29 had a high risk of attrition bias as the result of incomplete reporting of outcome data, as only compliers were incorporated in the analysis and non-adhering participants were excluded. Selective reporting was found in four trials. 27, 29, 39, 49 Overall, when using the predefined criteria, the study level assessment showed that ten trials had a high risk of bias, [27] [28] [29] [30] [31] [32] 35, 45, 47, 49 three had a low risk of bias 41, 43, 48 and the remaining ten studies were considered to have an unclear risk of bias 33, 34, [36] [37] [38] [39] [40] 42, 44, 46 ( Figure S1 ). Funnel plots for the different outcomes did not indicate any publication bias ( Figure S2 ).
| Body weight
Of the 20 studies that incorporated changes in body weight as an outcome, 17 provided sufficient information to be included in the metaanalysis and comprised 739 participants randomised to the LCD and 848 randomised to the HCD. Overall, an LCD was not associated with greater weight loss than an HCD in either short-or long-term studies (Figure 2A ), but subgroup analysis suggested more positive results in short-term studies (≤6 months) than in studies with longer follow up (Table S3A ). Sensitivity analysis showed less difference between LCDs and HCDs in studies with a low risk of bias than in studies with a high risk of bias (Table S3C ). In the three cross-over studies of 3-month duration 28, 29, 38 that did not fulfill criteria for inclusion in the metaanalysis, one 38 showed greater weight loss associated with LCDs. The certainty of evidence was moderate, with little heterogeneity (I 2 = 29%) (Table S4 ).
| Glycaemic control
LCD was associated with greater overall reduction in HbA1c (MD, in the 16 studies included in the analysis. This result is largely driven by the results of the short-term studies ( Figure 2B and Table S3A ) and by trials associated with a high risk of bias (Table S3C) . Of the three short-term studies not included in the meta-analysis, 28,29,38 one 38 showed greater improvements with LCDs. The evidence was considered as having moderate certainty for this outcome (Table S4) . low evidence), ( Figure 3D and Table S4 ). There was evidence of considerable between-study heterogeneity for triglycerides (I 2 = 57%; P < 0.003), for HDL-cholesterol (I 2 = 72%; P < 0.0001), for LDLcholesterol (I 2 = 64%; P = 0.0004) and for total cholesterol (I 2 = 71%;
The reasons for the observed heterogeneity were explored in subgroup and sensitivity analyses. No consistent subgroup effects were observed across the three outcomes, although HDL-cholesterol was slightly higher with LCDs than with HCDs in long-term studies (P = 0.10) ( Figure 3B and Table S3A ) and LDL-cholesterol was higher in VLCD trials compared with moderate LCDs (P = 0.05) (Table S3B and Figure S3 ). Trials with low risk of bias showed less difference between LCDs and HCDs concerning changes in HDL-cholesterol and triglycerides than trials associated with high risk of bias, whereas the results were more consistent concerning LDL-and total cholesterol.
Sixteen trials examined the effect of an LCD on blood pressure.
As shown in Figure 4A and B, the pooled effect from the metaanalysis indicated no significant difference in the effect of an LCD on systolic blood pressure (SBP) and diastolic blood pressure (DBP) when compared to control (SBP: MD, −0.93 mm Hg; 95% CI, −2.24, 0.37; DBP: MD, −0.21 mm Hg; 95% CI, −1.20, 0.79). Two of the three studies that were not included in the meta-analyses showed a greater reduction in DBP in the LCD group. 36, 38 The certainty of evidence was considered low for both outcomes because of risk of bias and imprecision (Table S4) . No evidence of between-study heterogeneity was identified in the meta-analyses (I 2 = 0%).
| Compliance and attrition rate
By using 24-hour recalls or food records, nine out of 18 studies found that dietary intake of carbohydrates in the LCD were 5 E% within what was recommended. In seven out of nine trials that observed low FIGURE 3 Meta-analysis of changes in A, LDL-cholesterol, B, HDL-cholesterol, C, total cholesterol and D, triacylglyserols, all measured in mmol/ L, divided according to study duration compliance, participants were receiving VLCDs with 5 E% to 22 E% from carbohydrates. 31, 32, 34, 35, 37, 40, 42 Four of these studies were based on an Atkins diet. 34, 35, 37, 40 In the meta-analysis of attrition rates between LCD and HCD groups, no detectable difference in attrition was observed (RR, 1.08; 95% CI, 0.92, 1.27; I 2 = 0%) ( Figure 4C ).
Results were similar in trials associated with high and low risk of bias.
The certainty of evidence for attrition was downgraded to low because of risk of bias and imprecision (Table 4) .
| Carbohydrate and fat quality in the diets
Seven of the included studies gave no information regarding dietary intake or gave only information concerning macronutrient distribution.
Sixteen studies assessed dietary intake, 15 of which reported information regarding the nature of the carbohydrate (fibre, glycaemic index or load, sucrose, key foods provided in feeding trials). In nine of 15 trials the intake of fibre was higher in the HCD, while six trials reported no differences in fibre intake. Glycaemic index and glycaemic load were higher in the HCD in the two studies that reported this, while the intake of sucrose was lower in the LCD in one of the three trials that reported sucrose intake. In seven of the trials unsaturated fatty acids were substituted for carbohydrates in the LCDs, which resulted in a significantly higher intake of unsaturated fatty acids in the LCD compared with the HCD in six of the trials that reported fatty acid composition, while intake of saturated fat increased in only two of these studies. Ajala et al. 16 published a review and meta-analysis that examined the effects of low-carbohydrate, low-glycaemic index, high-fibre, high-protein, Mediterranean, vegetarian and vegan diets compared with control diets in trials that continued for 6 months or more. They reported a range of benefits, including an improvement in glycaemic control associated with all of these dietary patterns, and concluded that they were appropriate for individuals with diabetes. However,
given that neither the low-carbohydrate nor the comparator diets were clearly defined, it is not possible to separate the effect of carbohydrate quantity from other aspects of the diet on the various outcome measures. Our meta-analysis also included trials with a range of carbohydrate intake, but differences between low and higher intakes were clearly specified and we used a random effects analysis, rather than a fixed effect analysis, as used by Ajala and colleagues, 16 to take into account the heterogeneity of studies. On the other hand, Naude et al. 20 concluded that altering carbohydrate quantity led to no difference in either body weight or glycaemic control; however, their metaanalysis included only five trials that involved isoenergetic comparisons, thus limiting the opportunity to find differences in weight change or glycaemic control as a consequence of altering macronutrient distribution.
In a more recently published systematic review and meta-analysis, Snorgaard et al. 21 concluded, as we did, that the modestly beneficial effect with respect to glycaemia conferred by LCDs was apparent only in the short term. However, our analysis differed from their approach in that we considered the outcomes of the relatively short-and longterm trials separately, whereas five of the eight studies providing data from a 3-6-month period in the review by Snorgaard et al. were also the source of data at 12 months. They also reported that the effect on glycaemic control was related to the extent of carbohydrate restriction. This association was totally dependent on the findings of two trials 50, 51 with a duration of 3 months that were not included in our analyses because they involved participants with prediabetes 50 or an additional physical activity intervention. 51 When forest plots for VLCD diets and moderate LCD diets were examined separately, there appeared to be a better effect of VLCDs on HbA1c , also in our metaanalysis, but post-hoc subgroup analysis did not confirm this. On the contrary, the subgroup analysis showed that VLCDs had a less favourable effect on LDL-cholesterol compared with HCDs, while this difference was not shown in studies using moderate LCDs. Several issues must be taken into account when translating these findings into nutritional advice for individuals with type 2 diabetes.
Weight reduction was a goal in the majority of the studies and the improvements seen with LCDs were observed mainly when weight loss was achieved. Thus, it is unclear whether the patient would bene- Further long-term dietary intervention studies, taking into account both the amount and source of carbohydrate, would be helpful in refining nutritional recommendations for individuals with diabetes. However, in practice, nutrition recommendations require translation into dietary patterns in order for them to be implemented.
On the basis of currently available systematic reviews and metaanalyses there is an appreciable body of evidence to suggest that a traditional Mediterranean-type diet is particularly appropriate for individuals with T2DM. 16, [52] [53] [54] Mediterranean diets vary in the proportion of energy provided by macronutrients, but are typically rich in pulses, fruits, vegetables and nuts, with olive oil being a major contributor to fat intake. Other dietary approaches, including a healthy Nordic diet and vegetarian diets, may also be beneficial for individuals with diabetes. 16, 52, [54] [55] [56] [57] [58] [59] None of these dietary patterns is particularly low or high in carbohydrate. The range of possible diets allows personal preference to play a key role, while permitting appreciable restriction of rapidly digested starches and sugars in those with insulin resistance. While energy balance remains a cornerstone of all dietary advice for individuals with diabetes, the proportion of macronutrients seems to be less important.
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